Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Chief Executive Markku Jalkanen buys 25,000 shares at an average price of €2.82, worth €70,533, on Tuesday.
Current stock price: 225.00 pence
12-month change: down 35%
Copyright 2022 Alliance News Limited. All Rights Reserved.